News
Please, enter cell line, author or any other phrase or word you would like to search for.
Sahlgrenska Acquires Second HoloMonitor System
After an initial purchase by Sahlgrenska University Hospital, Sahlgrenska Center for Cancer Research acquires a second HoloMonitor system.
BioSpherix Partnership Yields HoloMonitor Customer in Regenerative Medicine
Recently, the EU-funded Centre for Innovative Medicine in Vilnius purchased its first HoloMonitor analyzer for use in the center’s incubator system from BioSpherix.
Harvard Researchers Purchase HoloMonitor
Partners HealthCare International in Boston, Massachusetts, recently ordered its first and fully equipped HoloMonitor unit.
Interim Report 3 (2020-11-01 – 2021-01-31)
The second wave of the pandemic restricted sales during the 3rd quarter. However, the situation has improved significantly since late January.
PHI Secure Working Capital Until 2023
PHI has received a second loan commitment of 20 MSEK. In total, the company has received loan commitments of 35 MSEK that are expected to secure the company’s working capital until 2023.
Interim Report 2 (2020-08-01 – 2020-10-31)
The relaxed COVID-19 restrictions during the 2nd quarter led to a noticeable increase in sales.
Interim Report 1 (2020-05-01 – 2020-07-31)
The global COVID-19 restrictions have dramatically affected customers’ ability to receive us for onsite demonstrations, installations and customer training. Despite this, several HoloMonitor units have been delivered since the beginning of the fiscal year in May.
PHI improves search engine ranking by enhancing website performance significantly
PHI improves website ranking by enhancing website performance significantly.
PHI granted patent on synthetic antibodies in the U.S.
PHI announces today that the Company has been granted a patent on synthetic antibodies from the United States Patent and Trademark Office.
Year-end Report 2019/20
To emerge stronger from the pandemic than entering it, we have for the time being focused our resources on reducing sales cost, improving our market visibility and expanding the HoloMonitor product line.